“From cost savings to increased completion rates, VirTrial not only has an impressive vision for creating a hyper-efficient hybrid virtual trial model, but they have the data to back it up,” said James Johnson, managing director, MedTech Breakthrough.
SCOTTSDALE, Ariz. (PRWEB) June 13, 2019
VirTrial was recently awarded Best New Technology Solution in the 2019 MedTech Breakthrough awards program in the drug development category. The company was also named winner of three Gold Stevie® Awards in the Health & Pharmaceuticals - Service, Cloud Application/Service, and Healthcare Technology Solution categories in the 2019 American Business Awards®. In addition, VirTrial won the People’s Choice Stevie® Award in the Health & Pharmaceuticals category.
“I’m honored that VirTrial was recognized by the MedTech Breakthrough awards program and the American Business Awards and I congratulate all fellow award winners,” said Mark Hanley, CEO, VirTrial. “Our mission at VirTrial is to provide technology solutions that reduce the burden on patients and support research site sustainability. Ultimately, the goal is to increase efficiency in clinical trials across the industry and help bring new medications to market faster.”
VirTrial’s winning solution, the Patient Management Program, is a new breed of virtual trial platform that offers a hybrid approach for clinical trials that require a combination of in-clinic and virtual visits. Its combined video, text, and email offer convenience to patients that can speed patient recruitment, increase retention, and generate improved outcomes. Unlike other virtual trial offerings, VirTrial’s Patient Management Program is the only solution that operates on any device, including participants’ personal devices, (Apple, Android, smartphone, tablet, computer) and at any research site.
“From cost savings to increased completion rates, VirTrial not only has an impressive vision for creating a hyper-efficient hybrid virtual trial model, but they have the data to back it up,” said James Johnson, managing director, MedTech Breakthrough. “We are proud to be able to recognize such an innovative company, especially one helping to empower others to innovate with creative pathways in pharmaceutical and drug development. Congratulations to the entire VirTrial team on their well-deserved 2019 MedTech Breakthrough Award.”
Judges from the American Business Awards made the following comments: “VirTrial’s Patient Management Program is the only solution that operates on any device. The entry is truly above and beyond with all supporting documents. Outstanding work!” and “VirTrial’s Patient Management Program has the potential for titanic growth.”
For more information on VirTrial’s virtual clinical trial app, go to http://www.VirTrial.com.
VirTrial is a technology company using a stable, long-standing telehealth platform to transform the clinical trials industry. The platform offers a patient management program that combines video, text, and email allowing pharmaceutical companies and CROs to create patient centric trials by replacing some study visits with virtual visits. The vision is for 25-50% of the visits to be conducted virtually creating a hybrid model. This model is ideally suited for Phase III/Phase IV trials where patient compliance can be assessed from any location. Our Patient Management Program allows sites to create efficient automated messaging. The VirTrial app is supported on any device (Android, Apple, smartphone, tablet, computer) and can be used by any site. It is hosted in a secure, cloud-based, environment and is HIPAA compliant.
VirTrial enables greater accessibility to trials for patients, higher performance by clinical trial sites, and improved outcomes for pharmaceutical companies. Working together we can bring better medications to market more quickly. To learn more about VirTrial, visit https://www.VirTrial.com.
For more information about MedTech Breakthrough, visit MedTechBreakthrough.com.
Learn more about the Stevie Awards at http://www.StevieAwards.com.